This event has already occurred.

Monirul Islam, MD, PhD

Monirul Islam, MD, PhD

Patient-Defined Treatment Success and Preferences in Advanced-Stage Lung Cancer Patients


August 11, 2015, 12:30 p.m.


Monirul Islam, MD, PhD

Associate Professor of Epidemiology
College of Public Health
University of Nebraska Medical Center
Omaha, Nebraska


Fralin Biomedical Research Institute, R1059
2 Riverside Circle, Roanoke, VA 24016

Metastatic non-small cell lung cancer is a fatal disease that disproportionately affects older patients. Treatments have similar efficacies but different toxicity profiles. Thus, the definition of treatment success is dependent on individual patients’ tolerability of adverse events. Yet no clinician or patient guide exists on how to assess and integrate patient’s preferences of adverse events into the treatment planning process. Dr. Islam seeks to integrate non-small cell lung cancer patient treatment preferences into clinical treatment planning. He aims to determine whether individual patients’ preferences, characteristics, and treatment experiences affect the definition of treatment success; establish how to best predict real-life patient’s treatment choices based on patients’ preferences of adverse events; and explore whether physicians are likely to change their oncologic clinical practice after receiving a detailed communication of their patients’ preferences of adverse events.

Additional Details

This is a free event. The host is Michael Friedlander, PhD. For more information, please send an e-mail.

Map and Parking

This map shows where the Fralin Biomedical Research Institute is located in Roanoke, VA at 2 Riverside Circle.

Parking is available in the parking garage across the street.

Click the "Google" logo for a larger version.

Event Type